March 24 (Reuters) - Pharmaceutical company Merck is nearing a roughly $6 billion all-cash deal to acquire biotech firm Terns ...
Merck & Co. Inc. MRK is nearing an all-cash deal to acquire Terns Pharmaceuticals, Inc. TERN for roughly $6 billion, aiming ...
Merck & Co. is in advanced talks to buy drugmaker Terns Pharmaceuticals Inc., according to people familiar with the matter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results